Products

(S)-3-Aminobutanenitrile hydrochloride is a chiral β-aminonitrile hydrochloride salt featuring a specific (S)-configured stereocenter at the third carbon position. The combination of an amino group (–NH₂) and a nitrile group (–CN) on a chiral scaffold, along with the hydrochloride salt form, provides excellent stability and water solubility, making it a crucial chiral building block in asymmetric synthesis and pharmaceutical development.

3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-2-(4-methoxyphenyl)-, (2R,3R,4S)-, (αS)-α-hydroxybenzeneacetate features a chiral 2,4-diaryl-substituted pyrrolidine-3-carboxylic acid core, a pharmacophore framework pioneered by Abbott Laboratories in the discovery of potent endothelin (ET) receptor antagonists such as A-127722 (atrasentan). The pyrrolidine ring bears three contiguous stereocenters at the 2R, 3R, and 4S positions, each essential for precise three-dimensional orientation required for high-affinity binding to the ETA receptor. The (4-methoxyphenyl) group at the 2-position and the (1,3-benzodioxol-5-yl) moiety at the 4-position contribute to lipophilic and electronic complementarity within the receptor’s binding pocket. The carboxylic acid at the 3-position serves as a hydrogen bond donor/acceptor for key active-site interactions. This compound is isolated as a salt with (αS)-α-hydroxybenzeneacetic acid (L-mandelic acid), a chiral resolving agent that stabilizes the enantiomerically pure (2R,3R,4S) configuration for downstream pharmacological applications.

3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-2-(4-methoxyphenyl)-, ethyl ester, (2α,3α,4α)- (CAS 173937-93-4) is a chirally complex 2,4-diarylpyrrolidine-3-carboxylic acid ethyl ester featuring three contiguous stereocenters in the (2α,3α,4α) configuration. This absolute stereochemical arrangement—specifically the trans,trans orientation of the two aryl substituents across the pyrrolidine ring—is the defining pharmacophoric signature of Abbott Laboratories’ seminal class of potent and selective endothelin A (ETA) receptor antagonists. The 4‑position bears a 1,3‑benzodioxole group, a metabolically stable isostere that enhances lipophilicity and contributes to optimized receptor occupancy. The 2‑position carries a 4‑methoxyphenyl ring, while the 3‑position features an ethyl carboxylate moiety that serves as a versatile handle for late‑stage functionalization via amidation or reduction. This precisely defined (2α,3α,4α) stereochemistry is not merely a structural nuance—it is the critical determinant of the high‑affinity ETA binding that enabled the discovery of the blockbuster drug Atrasentan (ABT-627).

1-Chloro-2-(chloromethyl)-3,5-dioxahexane, systematically named 1,3-dichloro-2-(methoxymethoxy)propane, is an acyclic, halogenated diether characterized by a central methine carbon flanked by two chloromethyl groups (–CH₂Cl) and a methoxymethyl (–OCH₂OCH₃) substituent. The combination of an electrophilic, α-haloalkyl ether structure with two labile chloromethyl moieties provides three distinct points for nucleophilic attack, positioning it as a uniquely versatile, three-pronged alkylating agent for constructing elaborate synthetic intermediates. This reactivity pattern makes it a valuable synthetic intermediate for the preparation of more complex molecules, particularly in pharmaceutical manufacturing and advanced organic synthesis.

Fumaric Acid Monoethyl Ester Zinc Salt (2:1) is an organometallic coordination compound formed by the reaction of the monoethyl ester of fumaric acid with zinc ions in a precise 2:1 molar ratio. The two monoethyl fumarate ligands coordinate to a central Zn²⁺ ion through their carboxylate groups, producing a discrete molecular salt whose bioactivity stems from its ability to release both the anti‑psoriatic monoethyl fumarate ligand and zinc ions in biological systems. This unique dual-release mechanism positions the compound as a promising candidate for pharmaceutical and biomedical applications.

5-[(1E)-2-nitroethenyl]-1,3-benzodioxole (CAS 22568-48-5), also widely recognized as 3,4-methylenedioxy-β-nitrostyrene (MNS), is a structurally distinct β-nitrostyrene derivative characterized by the fusion of a 1,3-benzodioxole ring (commonly known as a methylenedioxy moiety) with a trans-configured nitroethenyl side chain. The 1,3-benzodioxole system at its core, a planar aromatic scaffold, contributes significantly to the lipophilic character of the molecule, while the conjugated nitroethenyl (-CH=CH-NO₂) group constitutes an electrophilic Michael addition acceptor. This extended conjugation between the electron-rich aromatic benzodioxole ring and the electron-withdrawing nitro group across the trans-double bond gives 5-[(1E)-2-nitroethenyl]-1,3-benzodioxole its distinctive yellow coloration and its versatile chemical reactivity.